Sarah, M., Khadidja, H., Keltoum, D., Asma, T., Abdelkrim ‬‬, A. (2022). The Use of Syzygium aromaticum L. to Avoid and Control the SARS-CoV-2 Related Complications. test, 14(1), 77-89. doi: 10.21608/eajbsc.2022.215048
Mellali Sarah; Haoud Khadidja; Dermeche Keltoum; Tamert Asma; Aroussi‬ Abdelkrim ‬‬. "The Use of Syzygium aromaticum L. to Avoid and Control the SARS-CoV-2 Related Complications". test, 14, 1, 2022, 77-89. doi: 10.21608/eajbsc.2022.215048
Sarah, M., Khadidja, H., Keltoum, D., Asma, T., Abdelkrim ‬‬, A. (2022). 'The Use of Syzygium aromaticum L. to Avoid and Control the SARS-CoV-2 Related Complications', test, 14(1), pp. 77-89. doi: 10.21608/eajbsc.2022.215048
Sarah, M., Khadidja, H., Keltoum, D., Asma, T., Abdelkrim ‬‬, A. The Use of Syzygium aromaticum L. to Avoid and Control the SARS-CoV-2 Related Complications. test, 2022; 14(1): 77-89. doi: 10.21608/eajbsc.2022.215048

The Use of Syzygium aromaticum L. to Avoid and Control the SARS-CoV-2 Related Complications

Egyptian Academic Journal of Biological Sciences. C, Physiology and Molecular Biology
Article 8, Volume 14, Issue 1, June 2022, Pages 77-89    PDF (726.74 K)
Document Type: Original Article
DOI: 10.21608/eajbsc.2022.215048
Authors
Mellali Sarah1; Haoud Khadidja2; Dermeche Keltoum1; Tamert Asma1; Aroussi‬ Abdelkrim ‬‬3
1Department of Biological Sciences, Faculty of Science and Technology, Relizane University, Relizane, Algeria.
2Department of Biology, Faculty of Natural and Life Sciences, Djillali Liabes University, Sidi Bel Abbes, Algeria
3Department of Biological Sciences, Faculty of Science and Technology, Relizane University, Relizane, Algeria
Abstract
Objective: As part of the fight against COVID 19, various phytochemicals obtained from medicinal plants and natural products are being explored as alternative and complementary solutions to treat contaminated patients. The current study aimed to evaluate the efficacy of one of the most popular: clove or “Syzygium aromaticum L.”
Materials and Methods: In this sense, we conducted a cross-sectional descriptive study of 100 patients between the ages of 21 and 80, diagnosed positive for Covid-19, between October 2020 and January 2021, and administered between 2 and 3 clove buds, twice daily.
Results and discussion: Our study revealed that patients between the ages of 30 and 39 were the most affected, with women being the predominant (75%). The scanner showed a moderate Covid-19 attack (10-25%) in 72% of patients. Dried clove was used by 85% of patients, 81% of them noted an improvement in their overall condition after 48 hours of treatment. The use of clove is relatively significant with disease progression (p < 0,05). Indeed, complications were observed in the group of patients who did not use this medicinal plant.
Conclusion: Clove appears to be effective in the fight against COVID-19. It can be used to prevent and control symptoms associated with SARS-CoV-2.
Keywords
COVID-19; Clove; Effectiveness; Descriptive study
Statistics
Article View: 649
PDF Download: 890